F-Prime Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 30

Professionals
  • Investments
  • 461

  • Portfolio
  • 160

  • Exits
  • 134

Exits

F-Prime Capital General Information

Description

Founded in 1969, F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in information technology, healthcare, life sciences sectors in the United States and Europe..

Contact Information

Formerly Known As
Fidelity Biosciences
Year Founded
1969
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Impact Investing
Primary Office
  • 1 Main Street
  • 13th Floor
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

F-Prime Capital Investments (461)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Spry (Other Healthcare Technology Systems) 22-Jun-2022 Early Stage VC 000 Enterprise Systems (Healthcare) Generating Revenue 0000 00000
00000 16-Jun-2022 00000 00000 00000 IT Consulting and Outsourcing Generating Revenue
00000000 14-Jun-2022 00000 00000 0000 Decision/Risk Analysis Generating Revenue
0000000 09-Jun-2022 00000 00000 0000 Decision/Risk Analysis Generating Revenue 000000000 0000000 00.0
00000 (0000000000 08-Jun-2022 00000 00000 0000 Electronic Equipment and Instruments Generating Revenue
00000 (00000000 00 07-Jun-2022 0000 00000 00.000 Business/Productivity Software Generating Revenue
0000000000 02-Jun-2022 0000 00000 000 Other Healthcare Technology Systems Generating Revenue 0000 00000
00000000 12-May-2022 00000 00000 0000 Human Capital Services Generating Revenue 00000 000
CHARM Therapeutics 18-Apr-2022 Early Stage VC 0000 Biotechnology Startup
Eleos Health 05-Apr-2022 Early Stage VC 0000 Outcome Management (Healthcare) Generating Revenue 0000 00000
You’re viewing 10 of 461 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

F-Prime Capital Exits (134)

Company Name Exit Date Exit Type Exit Size
Ivenix 04-May-2022 Merger/Acquisition 00000
00000 31-Mar-2022 000000000000000000 00000
0000 000000000 17-Feb-2022 000000000000000000 00000
0000000 0000 12-Jan-2022 000000000000000000
0000000 000000 30-Dec-2021 000000000000000000
00000000000 000000 10-Dec-2021 000 00000
000000000 07-Dec-2021 0000000000
0000000 0000000000 04-Nov-2021 000 00000
Xilio Therapeutics 22-Oct-2021 IPO 00000
MineralTree 18-Oct-2021 Merger/Acquisition 00000
You’re viewing 10 of 134 exits. Get the full list »

F-Prime Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

F-Prime Capital Team (94)

Name Title Deals Funds Boards Office
Stephen Knight MD President & Managing Partner 00 0 00 Cambridge, MA
Stacie Weninger Ph.D President, FBRI 0 0 0 Cambridge, MA
Mary Pendergast Partner & Chief Operating Officer 0 Cambridge, MA
Amber Cai Ph.D Venture Partner Cambridge, MA
Eric Blatte Venture Partner Cambridge, MA
You’re viewing 5 of 94 team members. Get the full list »

F-Prime Capital Co-Investors (798)

Name With Exits Lead Partner Series Industry
Eight Roads 56 0 00 Series chart Industry bar
GV 00 0 0 Series chart Industry bar
ARCH Venture Partners 0 0 0 Series chart Industry bar
Maverick Ventures 0 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
You’re viewing 5 of 798 co-investors. Get the full list »